Versor Investments LP bought a new stake in shares of Chinook Therapeutics, Inc. (NASDAQ:KDNY – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 348,543 shares of the company’s stock, valued at approximately $13,391,000. Chinook Therapeutics accounts for about 2.3% of Versor […]
EcoR1 Capital LLC lowered its position in Chinook Therapeutics, Inc. (NASDAQ:KDNY – Free Report) by 35.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 445,550 shares of the company’s stock after selling 244,450 shares during the quarter. EcoR1 Capital LLC’s holdings […]
EcoR1 Capital LLC reduced its stake in Chinook Therapeutics, Inc. (NASDAQ:KDNY – Free Report) by 35.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 445,550 shares of the company’s stock after selling 244,450 shares during the period. EcoR1 […]
Suvretta Capital Management LLC increased its stake in Chinook Therapeutics, Inc. (NASDAQ:KDNY – Free Report) by 8.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,568,797 shares of the company’s stock after purchasing an additional 123,967 shares during the quarter. Chinook Therapeutics […]
Affinity Asset Advisors LLC lifted its holdings in Chinook Therapeutics, Inc. (NASDAQ:KDNY – Free Report) by 19.3% in the 1st quarter, HoldingsChannel.com reports. The fund owned 976,021 shares of the company’s stock after buying an additional 157,986 shares during the period. Chinook Therapeutics comprises approximately 7.5% of Affinity Asset Advisors LLC’s holdings, making the stock […]